China Universal Asset Management Co. Ltd. increased its stake in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 10.6% in the fourth quarter, according to the company in its most recent ...

Sana Biotechnology shares last traded at $3.29, with a volume of 1,449,717 shares trading hands. Analyst Upgrades and Downgrades SANA has been the topic of a number of recent analyst reports.

In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other smid-cap stocks. As the name suggests, smid-cap stocks have a valuation ...

We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In ...

Sana Biotechnology (NasdaqGS:SANA) is a well-funded cell and gene therapy innovator. Its therapies address significant unmet needs across oncology, central nervous system (CNS) disorders ...

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Sana Biotechnology (SANA – Research Report) yesterday and set a price target of $7.00. The company’s shares closed ...

Last week, Sana Biotechnology, a once-mysterious and still-buzzy biotech startup, released clinical trial results showing that it had managed to implant insulin-producing cells in the arm muscle ...

Short interest in Sana Biotechnology Inc (NASDAQ:SANA) increased during the last reporting period, rising from 37.10M to 50.28M. This put 46.55% of the company's publicly available shares short.

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other smid ...